Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Johnson and Johnson
Express Scripts
Baxter
Medtronic

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Levofloxacin In Dextrose 5% In Plastic Container patents expire, and what generic alternatives are available?

Levofloxacin In Dextrose 5% In Plastic Container is a drug marketed by Aurobindo Pharma Ltd, Baxter Hlthcare Corp, Fresenius Kabi Usa, Hikma Farmaceutica, Hospira Inc, and Inforlife. and is included in six NDAs.

The generic ingredient in LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER is levofloxacin. There are thirty-one drug master file entries for this compound. Sixty suppliers are listed for this compound. Additional details are available on the levofloxacin profile page.

Summary for LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Drug patent expirations by year for LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Recent Clinical Trials for LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
United States Department of DefensePhase 3
Novartis PharmaceuticalsPhase 3
Otsuka Pharmaceutical Co., Ltd.Phase 3

See all LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials

US Patents and Regulatory Information for LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER levofloxacin INJECTABLE;INJECTION 206919-001 Feb 10, 2016 AP RX No No   Start Trial   Start Trial   Start Trial
Inforlife LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER levofloxacin INJECTABLE;INJECTION 090343-003 Jul 7, 2011 AP RX No Yes   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER levofloxacin INJECTABLE;INJECTION 200674-001 Jun 19, 2013 AP RX No No   Start Trial   Start Trial   Start Trial
Baxter Hlthcare Corp LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER levofloxacin INJECTABLE;INJECTION 091397-001 Aug 8, 2013 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
McKesson
AstraZeneca
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.